ALDX stock forecast
Our latest prediction for Aldeyra Therapeutics, Inc.'s stock price was made on the Dec. 16, 2019 when the stock price was at 5.07$.
In the short term (2weeks), ALDX's stock price should underperform the market by -6.55%. During that period the price should oscillate between -11.46% and +13.10%.
In the medium term (3months), ALDX's stock price should underperform the market by -13.74%. During that period the price should oscillate between -42.02% and +25.87%.Get email alerts
About Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.16$ per share.
The book value per share is 1.76$
Three months stock forecastDec. 16, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|